(Press-News.org) VIDEO:
The video as it appears on JoVE.com.
Click here for more information.
On May 22, JoVE will publish details of a technique to measure the health of human genetic material in relation to a patient’s age. The method is demonstrated by the laboratory of Dr. Gil Atzmon at New York’s Albert Einstein College of Medicine. Dr. Atzmon hopes that the dissemination of this technique will lead to the development of a “genetic thermometer” to assess a patient’s health in relation to other individuals of the same age.
The JoVE publication will feature a technique that measures telomere length. Recently, telomeres have gained attention because they serve as “caps” to chromosomes. As such, they mark the ends of genetic material and ensure that genes do not degrade as cells divide. Starting with the first replication of DNA and division of a fertilized egg, chromosomes shorten because the DNA replication process is imperfect. Certain organs, like the stomach or skin, are composed of tissues that reconstitute themselves frequently. In these organs, and in young individuals, the telomerase enzyme extends telomeres with each division, negating chromosomal shortening that would otherwise occur. Telomerase activity declines as people age, and as a result telomeres shorten and can be responsible for age related afflictions and some cancers. Overall health can impact how quickly these telomeres degrade.
“Think of telomere length as though it was a thermometer. It measures the health of your genetic material,” Dr. Atzmon explains. “It tells you how fit you are in relation to the age you are. If you have longer telomeres you are in good shape, if you have shorter telomeres you are less fit for your age and are not in good health.”
Dr. Atzmon hopes that publication of this article will impact the ageing community by classifying health relative to an individual’s age. “I published in JoVE because I want more people to use the technique. As we [the medical community] collect more data, we can build a better index of age and health by population, and more accurately place a patient on the right spot in a continuum.”
Adoption of this technique will allow clinicians to monitor a patient’s health as they are treated, by comparing telomere degradation of a sick patient to other patients with that disease and to determine if treatment is slowing degradation. Dr. Kira Henderson, JoVE Editor and Director of Review, explains, “Telomere length and telomerase function impacts several realms of biological and medical research- from preventative aging models to cancer treatments. Maintaining the telomere is a pre-requisite to extending life and improving long-term health. It is our hope that the application of this JoVE video-article will elucidate relationships between disease state and telomere function and encourage advancement in this important field of study.”
###
Atzmon et. al.; http://www.jove.com/video/50246/telomere-length-telomerase-activity-yin-yang-cell
About JoVE, the Journal of Visualized Experiments:
JoVE, the Journal of Visualized Experiments, is the first and only PubMed/MEDLINE-indexed, peer-reviewed journal devoted to publishing scientific research in a video format. Using an international network of videographers, JoVE films and edits videos of researchers performing new experimental techniques at top universities, allowing students and scientists to learn them much more quickly. As of May 2013, JoVE has published video-protocols from an international community of nearly 6,000 authors in the fields of biology, medicine, chemistry, and physics.
URL: http://www.jove.com
To link to this release, please use this link: http://www.jove.com/about/press-releases/63
Contact:
Rachel Greene
Marketing Director
The Journal of Visualized Experiments
p. 617.250.8451
e. press@jove.com
Press Access
We offer complimentary access to verified press contacts. If you are interested in being on our press list, please create an account and send an email request to press@jove.com.
Please make sure to follow our Twitter account. If you have any questions or requests, contact us at press@jove.com.
How healthy are you for your age?
2013-05-22
ELSE PRESS RELEASES FROM THIS DATE:
Costs to treat stroke in America may double by 2030
2013-05-22
Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.
In a statement published in Stroke, an American Heart Association journal, the association cites the aging U.S. population as the main reason for the increases and predicts that by 2030:
Almost 4 percent of U.S. adults — nearly one in 25 — will have a stroke. This translates into an additional 3.4 million people with stroke in 2030.
Costs to treat stroke may increase ...
Taming suspect gene reverses schizophrenia-like abnormalities in mice
2013-05-22
Scientists have reversed behavioral and brain abnormalities in adult mice that resemble some features of schizophrenia by restoring normal expression to a suspect gene that is over-expressed in humans with the illness. Targeting expression of the gene Neuregulin1, which makes a protein important for brain development, may hold promise for treating at least some patients with the brain disorder, say researchers funded by the National Institutes of Health.
Like patients with schizophrenia, adult mice biogenetically-engineered to have higher Neuregulin 1 levels showed reduced ...
New archaeological 'high definition' sourcing sharpens understanding of the past
2013-05-22
A new method of sourcing the origins of artefacts in high definition is set to improve our understanding of the past.
Dr Ellery Frahm at the University of Sheffield developed the new technology to better study Mesopotamian obsidian tools unearthed in Syria, where cultural heritage is threatened by the ongoing conflict.
The research brings five decades of research full circle and presents a significant advance in the field. While at the University of Sheffield from 1965 – 1972, Professor Lord Colin Renfrew developed a technique that matched stone tools made of obsidian, ...
Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens
2013-05-22
NEW YORK, May 22, 2013. Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the Centers for Disease Control and Prevention—the bodies of most Americans. Once perceived as harmless, phthalates have come under increasing scrutiny. A growing collection of evidence suggests dietary exposure to phthalates (which can leech from packaging and mix with food) may cause significant metabolic and hormonal abnormalities, ...
Why the Super Bowl's location matters: Local ties still bind corporations: Study on philanthropy
2013-05-22
Toronto – If you're a small charity looking for some corporate largesse, pegging your ask to a big morale-boosting event planned for your community may help seal the deal, suggests a new study on corporate giving.
The paper found that corporate philanthropy spikes upward during "mega-events" such as the Olympics, the Super Bowl, or even political conventions. The finding goes against previous research that says corporate giving tends to stay stable.
"For non-profit managers, it suggests that one potentially reasonable strategy might be to tie some of their efforts in ...
Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine
2013-05-22
PASADENA, Calif. – May 22, 2013 — The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published today in Vaccine.
The U.S. Food and Drug Administration approved PCV13 for use beginning in 2010 after a series of trials. These trials found that PCV13, which protects against a broader range of pneumococcal types than the previously used PCV7, did not increase the risk for any serious adverse events related to the ...
Successful results in developing oral vaccine against diarrhea
2013-05-22
The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.
Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of diarrhea in children living in low and middle income countries result in 400 million diarrheal episodes and approximately 300 000 deaths among children per year.
ETEC is also the leading cause of illness among international travelers to developing countries. Among the 65 million people travelling from industrialized ...
2 miniature spider species discovered in Giant Panda Sanctuaries of China
2013-05-22
Two new minute spider species have been discovered from the Sichuan and Chongqing, China. The tiny new spiders are both less than 2 mm in length, with Trogloneta yuensis being as little as 1.01 mm and Mysmena wawuensis measured to be the even tinier 0.75 mm, which classes it among the smallest spiders known. The two species described in the open access journal Zookeys both have a bizarre body shape with disproportionately big spherical posterior body.
The family Mysmenidae to which the new species belong is composed of minute eight-eyed spiders. There are a relatively ...
Mechanism discovered which aids Legionella to camouflage itself in the organism
2013-05-22
The feared Legionella pneumophila bacteria is responsible for legionellosis, an infectious disease that can lead to pneumonia. In order to infect us, this pathogen has developed a complex method enabling it to camouflage itself and go unnoticed in our cells, thus avoiding these acting against the infectious bacteria.
Research led by the Basque biosciences research centre, CIC bioGUNE, in which teams from the National Institute of Health (NIH) of the USA and the National Supercomputation Centre in Barcelona (BSC) have also participated, has described for the first time ...
Magnetic fingerprints of superfluid helium-3
2013-05-22
This news release is available in German.
With their SQUIDs, low-temperature specialists of the Physikalisch-Technische Bundesanstalt (PTB) have made it possible for the magnetic moments of atoms of the rare isotope 3He (helium-3) to be measured with extreme sensitivity. With the aid of these sensors, highly sensitive nuclear resonance spectrometers were developed which have now provided deep insights into the state of matter at extremely low temperatures. In concrete terms, the international research group from London, Ithaca (USA), and PTB's Berlin Institute ...